Vericel Corporation share price logo

Vericel Corporation Share Price

NASDAQ: VCEL

Small Cap

$34.47

-0.89

(-2.53%)

Live

as on

Vericel Corporation Stock Performance

as on March 4, 2026 at 6:10 am IST

  • Day's Low

    Day's High

    $33.60
    $34.66
    downward going graph

    2.52%

    Downside

    0.55%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $29.24
    $52.06
    downward going graph

    15.17%

    Downside

    51.03%

    Upside

    downward going graph

Vericel Corporation share price movements today

Previous Close
$35.36
Open
$34.32
Volume
293.0K
Day's Low - High
$33.60 - $34.66
52 Week Low - High
$29.24 - $52.06

Vericel Corporation Historical Returns

1 Month Return
-4.69 %
3 Month Return
-5.43 %
1 Year Return
-28.58 %
3 Year Return
+ 12.86 %
5 Year Return
-16.01 %

Vericel Corporation Stock Fundamentals & Key Indicators

Check Vericel Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

0.41

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.19%

PE Ratio (TTM)

137.23

Industry PE ratio

8.581171171171171

PEG Ratio

0

EBITDA

22.6M

Revenue (TTM)

276.3M

Profit Margin

5.98%

Return On Equity TTM

5.11%

Vericel Corporation Stock Valuation

Track how Vericel Corporation P/E has moved over time to understand its valuation trends.

Vericel Corporation in the last 5 years

  • Overview

  • Trends

Lowest (-150.74x)

September 30, 2023

Industry (8.58x)

March 3, 2026

Today (137.23x)

March 3, 2026

Highest (149.61x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 137.23x

Vericel Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vericel Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Vericel Corporation image
Vericel Corporation
BUY$1.8B-16.01%137.235.98%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$126.2B133.18%32.4732.94%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$44.2B125.24%142.888.45%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.1BNA621.555.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$82.6B77.02%18.8331.41%

Stock Returns calculator for Vericel Corporation Stock including INR - Dollar returns

The Vericel Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vericel Corporation investment value today

Current value as on today

₹75,127

Returns

₹24,873

(-24.87%)

Returns from Vericel Corporation Stock

₹30,378 (-30.38%)

Dollar Returns*

₹5,505 (+5.5%)

Analyst Recommendation on Vericel Corporation Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Vericel Corporation. Average target price of $55.43

Vericel Corporation Share Price Target

Get share price movements and forecasts by analysts on Vericel Corporation.

What analysts predicted

37.81%UPSIDE

Target Price

$55.43

Current Price

$34.47

Analyzed by

12 Analysts

Target

$55.43

Vericel Corporation target price $55.43, a slight upside of 37.81% compared to current price of $34.47. According to 12 analysts rating.

Vericel Corporation Stock’s Investor Sentiment and Interest

Search interest for Vericel Corporation Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-12% versus previous 30 day period

Vericel Corporation Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
45
64
51
52
57
75
52
63
67
92
Gross Profit
30
48
35
36
41
58
36
46
49
73
Operating Income
-5
12
-5
-6
-2
18
-12
-2
3
22
EBITDA
-2
15
-2
-3
0
21
-8
2
8
27
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
1
1
1
1
1
1
2
2
2
-
Income Before Tax
-3
14
-3
-4
0
19
-11
0
5
24
Income Tax Expense
0
1
1
-
-
0
-
-
-
0
Net Income
-3
12
-3
-4
0
19
-11
0
5
23
Net Profit Margin
-8.03%
19.99%
-7.53%
-8.89%
-1.56%
26.28%
-21.38%
-0.87%
7.52%
25.01%

Vericel Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
54
63
90
117
124
156
164
197
237
276
Gross Profit
26
33
58
80
84
106
109
135
172
205
Operating Income
-19
-14
-3
-11
2
-7
-17
-6
4
11
EBITDA
-17
-14
-4
-7
5
-4
-11
2
16
30
Interest Expense
0
1
1
0
0
0
0
0
0
1
Depreciation
-
1
1
1
2
2
3
4
5
-
Income Before Tax
-19
-17
-8
-9
3
-7
-15
-2
10
17
Income Tax Expense
2
1
3
-1
0
0
0
0
0
0
Net Income
-19
-17
-8
-9
2
-7
-16
-3
10
16
Net Profit Margin
-35.98%
-27.04%
-8.96%
-8.20%
2.31%
-4.78%
-10.17%
-1.61%
4.37%
5.98%

Vericel Corporation Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
12
-3
-4
0
19
-11
0
5
23
Operating Cash Flow
10
7
18
10
22
6
8
22
15
Investing Cash Flow
-8
-25
-17
-21
-14
-15
-9
-3
-16
Financing Cash Flow
1
2
4
5
7
3
1
1
1
Change in Cash
3
-16
5
-5
14
-5
0
19
0

Vericel Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-17
-8
-9
2
-7
-16
-3
10
16
Operating Cash Flow
-13
0
-7
17
29
17
35
58
51
Investing Cash Flow
-1
-67
10
-17
-3
-36
-3
-79
-43
Financing Cash Flow
18
58
5
6
9
1
3
19
7
Change in Cash
3
-8
8
6
34
-17
35
-1
15

Global Institutional Holdings in Vericel Corporation

Funds
Holdings
State Street Corp
5.55%
Vanguard Group Inc
7.06%
FMR Inc
4.9%
BNP Paribas Investment Partners SA
2.5%
Loomis, Sayles & Company LP
2.09%
See all

Insights on Vericel Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -11.24M → 23.24M (in $), with an average increase of 707.6% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 52.59M → 92.91M (in $), with an average increase of 16.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.5% return, outperforming this stock by 62.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 47.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, VCEL stock has moved down by -7.6%

About Vericel Corporation

about vericel founded in 1989, vericel (formerly aastrom biosciences), is dedicated to the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. the company markets two cell therapy products in the united states, carticel® (autologous cultured chondrocytes), an autologous chondrocyte implant for the treatment of cartilage defects in the knee and epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. vericel is also developing maci, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee, and ixmyelocel-t, a patient specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (dcm). to fulfill vericel’s mission of helping people with severe diseases and conditions rea
OrganisationVericel Corporation
Headquarters64 Sidney Street, Cambridge, MA, United States, 02139
IndustryHealth Technology
CEOMr. Dominick C. Colangelo Esq.
E-voting on sharesClick here to vote

Key Management of Vericel Corporation

Name

Title

Mr. Sean C. Flynn

Chief Legal Officer

Ms. Karen Mahoney

Chief Human Resources Officer

Mr. Eric Burns

Vice President of Finance & Investor Relations

Mr. Michael Halpin

Chief Operating Officer

Mr. Joseph Anthony Mara Jr.

CFO & Treasurer

Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.

Chief Medical Officer

Mr. Jonathan D. Siegal

Principal Accounting Officer, VP & Corporate Controller

Mr. Roland DeAngelis

Chief Marketing Officer

Mr. Patrick J. Fowler

Senior Vice President of Corporate Development & Strategy

Mr. Dominick C. Colangelo Esq.

CEO, President & Director

FAQs

What is Vericel Corporation share price today?

Vericel Corporation share price today is $34.47 as on . Vericel Corporation share today touched a day high of $34.66 and a low of $33.6.

What is the 52 week high and 52 week low for Vericel Corporation share?

Vericel Corporation share touched a 52 week high of $52.06 on and a 52 week low of $29.24 on . Vericel Corporation stock price today i.e. is trending at $34.47,which is 33.79% down from its 52 week high and 17.89% up from its 52 week low.

What is Vericel Corporation's market capitalisation today?

Vericel Corporation market capitalisation is $0.00T as on .

How to invest in Vericel Corporation Stock (VCEL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vericel Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vericel Corporation Shares that will get you 0.0435 shares as per Vericel Corporation share price of $34.47 per share as on March 4, 2026 at 12:40 am IST.

What is the minimum amount required to buy Vericel Corporation Stock (VCEL) from India?

Indian investors can start investing in Vericel Corporation (VCEL) shares with as little as ₹92.074 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Vericel Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Vericel Corporation share’s latest price of $34.47 as on March 4, 2026 at 12:40 am IST, you will get 0.2901 shares of Vericel Corporation. Learn more about fractional shares .

What are the returns that Vericel Corporation has given to Indian investors in the last 5 years?

Vericel Corporation stock has given -16.01% share price returns and 25.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?